The sixth annual GENOMIC MEDICINE 2019 NORDIC conference will take place at the Kennedy Centre at Rigshospitalet in Copenhagen on 13th & 14th November.
This conference is organised in partnership with the Kennedy Centre at Rigshospitalet, Odense University Hospital and the Department of Clinical Genetics at Aarhus University Hospital.
Speakers include:
Prof Eske Willerslef, Natural History Museum of Denmark
Prof Richard Rosenquist Brandell, Karolinska Institute
Prof Jens Michael Hertz, Odense University Hospital
Dr Pekka Ellonen, Finnish Institute of Molecular Medicine
Dr Cathrine Jespersgaard, Danish National Genome Center
Dr Markus Heidenblad, Clinical Genomics Lund
Dr Rikke Olsen, Aarhus University Hospital
Dr Lars Feuk, Uppsala University
The conference will focus on the use of Genomics & Next Generation Sequencing (NGS) technologies and tools to look at human disease both in research as well as in a clinical setting.
There will also be a clinical NGS Data Analysis Workshop on 12th November led by our hospital partners that include the bioinformatics team at Odense University Hospital. The workshop is aimed at the analysis of the data as well as the clinical interpretation of variants.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM